{"anticipatedPostingDate":"2026-09","denomUnitsSelected":"Participants","description":"rPFS2 by BICR is defined as time from the date of crossover (ARDT to 177Lu-PSMA-617) to the date of radiographic disease progression by BICR or death from any cause for participants who crossover from ARDT arm to Lu-PSMA treatment.","reportingStatus":"NOT_POSTED","timeFrame":"From date of crossover until second radiographic progression or death, whichever comes first, assessed up to approx. 32 months","title":"Radiographic Progression Free Survival 2 (rPFS2) by Blinded Independent Central Review (BICR)","type":"SECONDARY"}